In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Christine Rousseau, a program officer at the foundation, describes the importance of diagnostics in HIV/AIDS and tuberculosis (TB) care and treatment and writes, “This brings me to the tremendous role that China’s entrepreneurs can play as partners in global health. China is a country with a huge capacity for innovation as well as the resources required to create new products. We believe that China is uniquely positioned to develop new health technologies that can benefit people in the developing world faster and more effectively than product developers elsewhere.” She notes “the HIV and TB teams of the Bill & Melinda Gates Foundation will be presenting the business case for a new generation of diagnostics to Chinese researchers, product developers, and investors at the China Diagnostics Conference in Shanghai on September 25 and 26” (9/24).
Private Sector Involvement
“Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs),” Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post’s “Impact” blog. He asks, “So how well is the private sector doing in tackling the rising pandemic of NCDs, which cause nearly two out of every three deaths in the world (80 percent of those in developing countries), the four main ones being cancer, cardiovascular disease, chronic respiratory disease and diabetes?” He continues, “The private sector is a major stakeholder in many ways — as employers; makers of food and medicines, sports gear and technology; as corporate citizens and consumers — and wants to be engaged in the global NCD dialogue. We deserve a seat at the table.”
“As the World Economic Forum kicks off this week in Davos, Switzerland, the importance of global health — and the health of the globe — is getting special attention,” Karl Hofmann, president and CEO of Population Services International (PSI), writes in this post in The Hill’s “Congress Blog.” He continues, “The world’s still massive bottom of the economic pyramid — some 2-3 billion people — represents a potential $5 trillion in purchasing power,” but without access to “quality health care and services, … their global economic impact suffers. Imagine if by simple investments in health, we turned these struggling individuals and families into healthy, active consumers and producers.”
“Innovative approaches and technologies as well as a strong political will from countries are essential to combat hunger,” according to U.N. Secretary-General Ban Ki-moon, who spoke Thursday night in Des Moines, Iowa, at an event to recognize the winner of the World Food Prize, the U.N. News Centre reports. This year’s winner, Israeli scientist Daniel Hillel, developed “a new mode of bringing water to crops iÂÂn arid and dry regions, known as ‘micro-irrigation,’” the news service notes. An end to hunger “calls for harnessing the creativity of scientists and economists,” Ban said, adding, “It requires developing new approaches and technologies to respond to climate change, water scarcity and desertification,” according to the news service (10/18). “There is enough food to feed seven billion people, but because of climatic conditions, because of supply, market price volatility, there are still 870 million people who are going to bed hungry every night,” Ban said, the Des Moines Register notes.
Deutsche Welle examines the widespread lack of access to medical supplies and drugs in developing countries and efforts by the pharmaceutical industry and others to bring new and lower-cost drugs into these emerging markets. Christian Wagner-Ahlfs of the Federal Coordination of Internationalism, or BUKO, which brings together 130 German activist groups to examine the work of the pharmaceutical industry in developing nations, said new drug prices in particular are “totally exorbitant,” adding, “It is a major problem that the companies do not reveal their actual research costs, so the prices are difficult to control,” according to DW. However, Norbert Gerbsch, deputy managing director of the Federation of German Industry (BPI), said those nations also have a responsibility to improve their health care infrastructure and food security, the news agency reports.
“I’ve always believed that bringing together the world’s brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health,” entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece. He says he will address this issue in a talk in San Francisco at TEDxSF, which “will explore crucial questions addressing the cutting-edge intersection of technology, medicine, scientific research, and industry at UCSF on November 10, 2012.”
The Humanitarian Centre’s latest Cambridge International Development report (.pdf), titled “Partnerships for global health: pathways to progress,” “provides insights from global health leaders on why partnerships provide a good structure for reciprocal ‘teaching and learning’” and “highlights examples of innovative partnerships — particularly those where the traditional ‘recipient’ of development aid has taken the leading role in providing ideas and ingenuity for global health,” the PLoS “Speaking of Medicine” blog reports. The report comprises several essays, case studies, and other collections of writing from experts in the field, researchers, and politicians, the blog notes (Radl, 10/26).
Inadequate Government TB Program, Lax Drug Sale Regulations Contributing To MDR-TB Cases In India, Health Groups Say
“India’s inadequate government-run tuberculosis [TB] treatment programs and a lack of regulation of the sale of drugs that fight the disease are responsible for the [increasing] number of drug-resistant cases that are difficult to treat,” health advocacy organizations said in India last week, the Associated Press/Huffington Post reports. “India adds an estimated 99,000 cases of drug-resistant TB every year, but only a tiny fraction of those infected receive the proper” six- to nine-month antibiotic regimen, according to the AP. In India, government-run TB treatment programs only provide drugs to patients on alternate days, increasing the likelihood of missed doses, and patients increasingly are turning to private physicians who are unaware of how to treat the disease, Medecins Sans Frontieres in India and other health groups said, the news agency reports. “The Indian government had no response Friday to requests for comment on the activists’ allegations,” the AP writes (Naqvi, 3/23).
VOA News reports on a March 20 panel meeting in Washington, D.C., that highlighted the contributions of corporations and non-governmental organizations (NGOs) to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Chevron, which has “invested $30 million for the three-year period between 2008 and 2011 and has pledged another $25 million through 2013,” was recognized at the meeting as “the first Global Fund Corporate Champion,” according to VOA (DeCapua, 3/23).
“At a public event [held Tuesday] on Capitol Hill, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Friends of the Global Fight Against AIDS, Tuberculosis and Malaria spotlighted the contributions of public-private partnerships to the Global Fund’s lifesaving work,” a joint press release (.pdf) reports. The event highlighted the “unique and essential roles” that partners like Chevron, the Coca-Cola Company, (RED) and PEPFAR play in improving lives around the globe, “[f]rom assistance in drug delivery, to supplying much-needed resources, to mobilizing consumer markets, to in-country partnerships,” according to the press release. “The partners highlighted at the Capitol Hill event have not only provided funding, but have also brought their individual expertise to the Global Fund, sharing their knowledge and building bridges between the public, private and health sectors,” the press release states (3/20).